Holen Sie sich die Stockscreener-App
14.94
2.47%
0.36
Handel nachbörslich:
14.94
Schlusskurs vom Vortag:
$14.58
Offen:
$14.9
24-Stunden-Volumen:
605.18K
Relative Volume:
0.87
Marktkapitalisierung:
$448.04M
Einnahmen:
$40.61M
Nettoeinkommen (Verlust:
$-29.07M
KGV:
-14.82
EPS:
-1.0081
Netto-Cashflow:
$-26.70M
1W Leistung:
+5.81%
1M Leistung:
-16.26%
6M Leistung:
+15.55%
1J Leistung:
+43.65%
1-Tages-Spanne:
$14.23
$14.97
1-Wochen-Bereich:
$13.82
$14.97
52-Wochen-Spanne:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
14.94 | 437.85M | 40.61M | -29.07M | -26.70M | -1.0081 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2023-10-24 | Eingeleitet | Stifel | Buy |
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
Clearpoint Neuro Inc (CLPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BlackRock (CLPT holder) discloses 7.1% beneficial stake in ClearPoint Neuro - Stock Titan
CLPT|Clearpoint Neuro Inc|Price:14.412|Chg%:+0.291 - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.813|Chg%:+0.693 - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.261|Chg%:-0.339 - TradingKey
Clearpoint Neuro Inc (CLPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Clearpoint Neuro Inc (CLPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clearpoint Neuro Inc (CLPT) Balance Sheet - TradingKey
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clearpoint Neuro Inc (CLPT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.120|Chg%:-0.370 - TradingKey
(CLPT) Risk Channels and Responsive Allocation - Stock Traders Daily
CLPT Q1 2026 Earnings: EPS Misses Estimates, Stock Still RisesRevenue Guidance Range - dars.gov.et
ClearPoint Neuro to announce Q2 2026 results on August 3 - scanx.trade
Articles from ClearPoint Neuro, Inc. - FinancialContent
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026 - ACCESS Newswire
ClearPoint Neuro Q2 review starts Aug. 3 at 4:30 p.m. ET - Stock Titan
ClearPoint Neuro Inc. (CLPT) Q1 2026 Earnings: EPS Misses Estimates, Stock Declines Over 3%Margin Expansion Trends - dars.gov.et
EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery - Contract Pharma
ClearPoint Neuro Slips Over 3% as Shares Test Key Support LevelsWave Equality - dars.gov.et
Why I've (Reluctantly) Sold My ClearPoint Neuro Position (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (CLPT) Q1 2026 Earnings: EPS Misses Estimates as Losses Widen, Shares DipRevenue Surprise History - dars.gov.et
ClearPoint Neuro (CLPT) surges 26.0%: Is this an indication of further gains? - MSN
Form 4 Clearpoint Neuro Inc For: 6 July By Investing.com - Investing.com Canada
Director at ClearPoint Neuro (NASDAQ: CLPT) receives 222-share stock grant - Stock Titan
ClearPoint Neuro (CLPT) Holds Steady Near $18.72 as Traders Eye Key Support and Resistance LevelsLong Term Entry Picks - dars.gov.et
CLPTClearPoint Neuro Inc Volatility & Greeks - Finviz
ClearPoint Neuro outlines growth ambitions in precision neurosurgery - Ad-hoc-news.de
Form 4 Clearpoint Neuro Inc For: 2 July By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CBO adds 1,781 ESPP shares, now holds 110,263 - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer STIGALL L. JEREMY - Moomoo
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer D'Alessandro Danilo - Moomoo
ClearPoint Neuro (CLPT) CFO acquires 1,085 shares through ESPP - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer BURNETT JOSEPH - Moomoo
Clearpoint Neuro Insider Sold Shares Worth $387,600, According to a Recent SEC Filing - marketscreener.com
ClearPoint Neuro CEO Burnett sells $387,600 in company shares By Investing.com - Investing.com Nigeria
ClearPoint Neuro CEO Burnett sells $387,600 in company shares - Investing.com
Form 4 Clearpoint Neuro Inc For: 1 July By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CEO exercises options and sells 20,000 shares under 10b5-1 plan - Stock Titan
Price to sales forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to book forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to earnings forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to EBITDA forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
(CLPT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Director sale notice, CLPT (NASDAQ: CLPT) — 20,000 shares via option exercise - Stock Titan
ClearPoint Neuro | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Enterprise value to EBIT forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to revenue forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
ClearPoint Neuro, Inc. Actuals & Estimates (NASDAQ:CLPT) - TradingView
CLPT Forecast — Price Target — Prediction for 2027 - TradingView
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Clearpoint Neuro Inc-Aktie (CLPT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH | CEO and President |
Jun 29 '26 |
Sale |
19.38 |
20,000 |
387,600 |
116,842 |
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):